Our results showed that EnSCs impaired the pro-angiogenetic ability of ovarian cancer cells in vivo through decreasing the expressions of VEGFA and HIF-1α in EOC cells, which might be mediated by EnSC-induced activation of FoxO3a in cancer cells. The gene discussed is HIF1A; the disease is ovarian carcinoma.